CLINICAL ROLE -
FCS Co-authored Study Confirms Effectiveness of Trilaciclib for Treatment of Patients with Extensive-Stage Small Cell Lung Cancer
Trilaciclib is the first FDA-approved therapy in its class to help protect bone marrow cells from damage caused by chemotherapy.
Precision Medicine at Scale is Here
Physicians can make an exact diagnosis and prognosis and plan treatment that targets a specific tumor with great precision.
Smoothies: A Healthy Choice?
Are smoothies as good as actually eating those fruits and vegetables?
Time to Treatment Matters After a Cancer Diagnosis
Swift treatment can improve cancer survival rates.
2 Clarke Drive Cranbury, NJ 08512